Latest News

Displaying articles 841 - 846 of 913 in total

FDA Consider Alemtuzumab

Thumbnail

For a number of years we have mentioned the possibility of a new drug called Alemtuzumab being a potential new treatment for people with MS. On 12 June 2012 the makers, Genzyme, announced that the company has made an official application to the Food and Drugs Administration (FDA) in the US and th...

Published by MS Ireland on Tuesday July 31 2012 07:29 PM

View Article

Gilenya Now Prescribed

Thumbnail

Fingolimod, under the trade name Gilenya, the first oral drug therapy for the treatment of MS, is now available under the direction of a neurologist. Gilenya is licensed as a second line therapy, making it suitable for people that have failed on conventional first line therapies or those individu...

Published by MS Ireland on Tuesday July 10 2012 11:21 AM

View Article

Your Space, Your Say!

Thumbnail

The MS Ireland blog is your space to talk about the things that matter to you. It's an opportunity to come together with a community of like-minded people and share your stories, advice and tips.  Of course, it's also a great place to ask questions, meet new ...

Published by MS Ireland on Thursday June 28 2012 03:35 PM

View Article

TDs to Support Carers

Thumbnail

Politicians from all parties are being encouraged by carers to sign a petition supporting the swift publication of the long awaited National Carers Strategy and for a timeframe for its implementation. The call was made as a delegation of family carers and carers organisations prepared to give a ...

Published by MS Ireland/Care Alliance Ireland on Thursday June 21 2012 12:32 PM

View Article

Carers Survey Findings

Thumbnail

Launch of the findings of a national survey of neurological carers as part of events to mark National Carers Week 2012 The survey was carried out by the Neurological Alliance of Ireland in partnership with Care Alliance Ireland. The survey, conducted last month, showed that most carers have bee...

Published by Neurological Alliance of Ireland/Care Alliance Ireland on Thursday June 21 2012 12:25 PM

View Article

Gilenya Funded

The HSE to now fund the oral therapy Yesterday The Irish Times reported that the HSE and the Irish Pharmaceutical Healthcare Association (IPHA) reached an agreement that will see the reimbursement of Gilenya, the oral therapy unavailable to people with MS. The IPHA represents the pharmaceutical ...

Published by MS Ireland on Wednesday June 20 2012 12:42 PM

View Article


Latest News

More news

What's hot

Trek

Treks 2018

Get active for MS and sign up to trek with us in 2018. Challenge yourself to trek to Everest Base Camp or join us in Jordan or Italy. The choice is yours!

Find out more

Events Calendar

» Our next Event

22 January 2018: Weekly yoga classes for people with MS. Ongoing throughout 2018. 

View all events

eNEWS SIGNUP

If you'd like to receive e-news updates from The Society please enter your email address below. If you want to know more about how we manage personal data then please see our privacy policy.

My local MSI

Map of MS Ireland's service areas South Mid West West Midlands South East North East North West North Dublin City and Fingal South West Dublin and Kildare South East Dublin and Wicklow